SimBioSys takes in $15m Series A

Chicago-based SimBioSys, a simulation-based, precision medicine platform, has raised $15 million in Series A funding.

26 October 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles